🔴 Lantern Pharma is trading 13.12% down today with no identified company-specific catalyst

Lantern Pharma is trading at $0.65, down 13.12%, as broader market weakness may be contributing to the October 30 decline.

• No new company-specific announcement explaining the move was identified in Lantern Pharma’s latest listed releases.
• The Nasdaq was down 2.32% in an intraday snapshot amid a technology-led selloff.
• The biotechnology ETF was up 0.4% in Friday premarket trading, so the decline was not clearly a sector-wide move.